Specific [3H]UK14,304 binding in human cortex occurs at multiple high affinity states with alpha2-adrenergic selectivity and differing affinities for GTP

Anne C. Andorn, Mark A. Carlson, R. Chapman Gilkeson

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Abstract

[3H]UK14,034 is a full agonist at α2-adrenergic receptors. Although the characteristics of the binding of the partial α2-adrenergic agonists in postmortem human brain were known, the binding of [3H]UK14,304 had not been studied in this issue. Multi-site binding of this radiolabel had been reported in other tissues and guanosine triphosphate (GTP) had been shown to reduce [3H]UK14,304 binding. We now report that [3H]UK14,304 labels at least 2 specific binding sites in human brain that both have the characteristics of an α2-adrenergic binding site. GTP decreases agonist binding at both of these sites, but with different potencies at each site.

Original languageEnglish (US)
Pages (from-to)1805-1812
Number of pages8
JournalLife Sciences
Volume43
Issue number22
DOIs
StatePublished - 1988
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Fingerprint Dive into the research topics of 'Specific [<sup>3</sup>H]UK14,304 binding in human cortex occurs at multiple high affinity states with alpha<sub>2</sub>-adrenergic selectivity and differing affinities for GTP'. Together they form a unique fingerprint.

Cite this